Physician profile
Allison J Brown
NPI 1366647562
$933.98
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $395 · 2020: $119 · 2021: $28.61 · 2022: $250 · 2023: $96.13 · 2024: $45.31.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $141.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $141.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $154.29 | 2019 | |
| Tela Bio, INC. | $127.50 | 2022 | |
| Janssen Scientific Affairs, LLC | $122.07 | 2022 | |
| Ucb, INC. | $94.22 | 2023-2024 | Bimzelx, Cimzia |
| Janssen Biotech, INC. | $68.32 | 2019-2023 | Tremfya |
| Abbvie INC. | $66.29 | 2019-2024 | |
| Novartis Pharmaceuticals Corporation | $65.17 | 2019-2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $47.34 | 2019 | |
| Lilly USA, LLC | $47.00 | 2019-2020 | |
| Amgen INC. | $29.16 | 2020 | |
| Galderma Laboratories, L.P. | $28.97 | 2019 | |
| Vyne Pharmaceuticals INC. | $22.06 | 2020 | |
| Aclaris Therapeutics, INC. | $16.91 | 2019 | |
| Pfizer INC. | $16.83 | 2019 | |
| Dermira, INC. | $16.57 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $11.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.